Takuma Kensuke, Okano Naoki, Ito Ken, Ujita Wataru, Iwata Shuntaro, Mizutani Saori, Nakagawa Hiroki, Watanabe Koji, Yamada Yuto, Kimura Yusuke, Yoshimoto Kensuke, Iwasaki Susumu, Hara Seiichi, Kishimoto Yui, Igarashi Yoshinori, Matsuda Takahisa, Amemiya Kazuki
Division of Gastroenterology and Hepatology, Toho University Omori Medical Center, Tokyo, Japan.
Department of Surgical Pathology, Toho University Omori Medical Center, Tokyo, Japan.
J Gastroenterol Hepatol. 2023 Jan;38(1):112-118. doi: 10.1111/jgh.16052. Epub 2022 Nov 16.
Stent-induced ductal change (SIDC) is a complication of endoscopic pancreatic stenting (EPS) in patients with chronic pancreatitis (CP). However, the evaluation of SIDC associated with S-type pancreatic plastic stent (PS) and large-caliber PS, such as 10 Fr, is limited. This study aimed to analyze the SIDC of the main pancreatic duct (MPD) associated with 10-Fr S-type PS in patients with CP.
Between January 2008 and December 2021, 132 patients with CP in whom a 10-Fr S-type PS had been installed by EPS were retrospectively reviewed. The SIDC incidence rate was examined, and the clinical features of patients with and without SIDC were investigated, including the outcomes for detected SIDC.
Stent-induced ductal change during EPS was confirmed in 41 patients (31.1%) of 132 patients at a site coincident with the PS tip or distal flap in the MPD. All patients were asymptomatic during the development of SIDC. Morphological changes in the MPD were detected as elevated (75.6%) or bearing stricture changes (24.4%). A total of 90.2% of SIDC developed after the first 10-Fr PS installation. No significant differences were noted between the patients with and without SIDC. The outcomes of continued PS installment for SIDC showed persistence and secondary change.
Stent-induced ductal change-associated 10-Fr PS installation was performed in just under one-third of the patients, indicating a substantial incidence rate and a possible development of SIDC from early stages onwards. More emphasis should be placed on SIDC as the complication.
支架诱导的导管改变(SIDC)是慢性胰腺炎(CP)患者内镜下胰管支架置入术(EPS)的一种并发症。然而,关于与S型胰管塑料支架(PS)及大口径PS(如10Fr)相关的SIDC的评估有限。本研究旨在分析CP患者中与10Fr S型PS相关的主胰管(MPD)的SIDC。
回顾性分析2008年1月至2021年12月期间132例行EPS置入了10Fr S型PS的CP患者。检查SIDC发生率,并调查有和无SIDC患者的临床特征,包括检测到SIDC的结局。
132例患者中有41例(31.1%)在EPS期间于MPD中与PS尖端或远端瓣膜重合的部位证实发生了支架诱导的导管改变。所有患者在SIDC发生期间均无症状。MPD的形态学改变表现为隆起(75.6%)或有狭窄改变(24.4%)。90.2%的SIDC在首次置入10Fr PS后发生。有和无SIDC的患者之间未观察到显著差异。针对SIDC继续置入PS的结局显示为持续存在和继发改变。
近三分之一的患者进行了与支架诱导的导管改变相关的10Fr PS置入,表明发生率较高且SIDC可能从早期就开始发生。应更重视SIDC这一并发症。